BIO-RAD LABORATORIES, INC.

BIO
Exchange
NYSE
Industry
Laboratory Analytical Instruments
SEC CIK
0000012208

Other share classesBIO.B

Price chart

Open-market purchases and sales by BIO insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
May 13, 2026May 11, 2026ENGELHARDT EVA ANETTEEVP, President, CDGSSaleBio-Rad A Common Stock−550$246.54−$135.6K346−61.4%SEC
Nov 10, 2025Nov 6, 2025BARRY JAMESEVP, President, LSGSSaleBio-Rad A Common Stock−699.87$306.18−$214.29K509.68−57.9%SEC
Mar 18, 2025Mar 14, 2025Crowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−3K$247.06−$741.18K8.17K−26.9%SEC
Sep 10, 2024Sep 6, 2024Last Andrew J.EVP, Chief Operating OfficerSSaleBio-Rad A Common Stock−3K$329.94−$989.82K7.56K−28.4%SEC
Sep 4, 2024Sep 4, 2024BARRY JAMESEVP, President, LSGSSaleBio-Rad A Common Stock−623$330.49−$205.9K146.56−81.0%SEC

The largest institutional positions in BIO at the end of Q2 2026.

Institutions holding BIO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
First Eagle Investment Management, LLC5,212,438$1.53B1.27%+2,609,666+100.3%Added
BlackRock, Inc.1,698,929$498.82M0.01%+18,869+1.1%Added
DIMENSIONAL FUND ADVISORS LP944,548$277.33M0.05%−144,775−13.3%Reduced
VANGUARD CAPITAL MANAGEMENT LLC826,972$242.81M0.01%−4,193−0.5%Reduced
ARIEL INVESTMENTS, LLC816,751$239.81M2.39%+30,790+3.9%Added